Vimarsana
Biggest News Aggregation in the World

Page 3 - Stringent Measures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stringent Measures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stringent Measures Today - Breaking & Trending Today

'Take Stringent Action Against Any Forced Conversion of LGBTIQ People': HC to Kerala Govt - Vimarsana News

'Take Stringent Action Against Any Forced Conversion of LGBTIQ People': HC to Kerala Govt

The petitioners at Kerala high court have alleged that there is forced conversion at the instance of the medical practitioners and that it creates several physical problems to members of the LGBTQI community.

Source: thewire.in
Ontario's COVID-19 Response: The Latest Developments | Stikeman Elliott LLP - Vimarsana News

Ontario's COVID-19 Response: The Latest Developments | Stikeman Elliott LLP

On October 25, 2021, the Government of Ontario began the process of easing its pandemic restrictions in accordance with its plan, announced on October 22, 2021, to carefully and...

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 - Vimarsana News

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 - Vimarsana News

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

ABBVie today announced the presentation of new data on RINVOQ ® SKYRIZI ® and HUMIRA ® across multiple rheumatic diseases at the American College of Rheumatology's annual meeting to be held virtually Nov. 3-9 . A total of 38 abstracts, including two oral presentations and one plenary session presentation, will be presented from a broad range of studies in rheumatoid arthritis, psoriatic arthritis and ankylosing ...

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 - Vimarsana News

AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab)...